Literature DB >> 1233205

Acetylation of procaine amide in man. A preliminary communication.

E Karlsson, G Aberg, P Collste, L Molin, B Norlander, F Sjöqvist.   

Abstract

The metabolism of procaine amide was studied in 41 cardiac patients who had achieved steady state plasma concentrations of the drug. Acetylated procaine amide accounted for 31 +/- 12% (range 16-63%) of the overall urinary recovery of the drug and is therefore a main metabolite in man. Plasma levels of the metabolite were usually lower but sometimes exceeded those of the parent compound with variations between 1 and 15 mug/ml. The metabolite had a weaker effect than procaine amide on the maximal electrical driving velocity of isolated atrial strips from guinea pig.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1233205     DOI: 10.1007/bf00616419

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  The physiological disposition and cardiac effects of procaine amide.

Authors:  L C MARK; H J KAYDEN; J M STEELE; J R COOPER; I BERLIN; E A ROVENSTINE; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1951-05       Impact factor: 4.030

2.  A new sustained-release tablet formulation of procainamide.

Authors:  D Fremstad; S Dahl; S Jacobsen; P K Lunde; K J Nådland; A A Marthinsen; T Waaler; K H Landmark
Journal:  Eur J Clin Pharmacol       Date:  1973-12       Impact factor: 2.953

Review 3.  Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis.

Authors:  H M Perry
Journal:  Am J Med       Date:  1973-01       Impact factor: 4.965

4.  Pharmacokinetics of procainamide.

Authors:  H S Weily; E Genton
Journal:  Arch Intern Med       Date:  1972-09

5.  Procainamide dosage schedules, plasma concentrations, and clinical effects.

Authors:  J Koch-Weser; S W Klein
Journal:  JAMA       Date:  1971-03-01       Impact factor: 56.272

6.  Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).

Authors:  A Hanngren; O Borgå; F Sjöqvist
Journal:  Scand J Respir Dis       Date:  1970

7.  Procainamide induction of a systemic lupus erythematosus-like syndrome. Presentation of six cases, review of the literature, and analysis and followup of reported cases.

Authors:  E L Dubois
Journal:  Medicine (Baltimore)       Date:  1969-05       Impact factor: 1.889

8.  Genetic variations in the acetylation of isoniazid and other drugs.

Authors:  D A Evans
Journal:  Ann N Y Acad Sci       Date:  1968-07-31       Impact factor: 5.691

9.  Metabolism of procainamide in rhesus monkey and man.

Authors:  J Dreyfuss; J T Bigger; A I Cohen; E C Schreiber
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

10.  A comparison of tests for antifibrillatory action.

Authors:  E M WILLIAMS; L SZEKERES
Journal:  Br J Pharmacol Chemother       Date:  1961-12
View more
  8 in total

1.  Pharmacokinetics in man of the N-acetylated metabolite of procainamide.

Authors:  J M Strong; J S Dutcher; W K Lee; A J Atkinson
Journal:  J Pharmacokinet Biopharm       Date:  1975-08

2.  Pharmacokinetics of sulphamethoxazole in man: effects of urinary pH and urine flow on metabolism and renal excretion of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole.

Authors:  T B Vree; Y A Hekster; A M Baars; J E Damsma; E van der Kleijn
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

3.  Acetylator phenotype and the clinical pharmacology of slow-release procainamide.

Authors:  W Campbell; W J Tilstone; D H Lawson; I Hutton; T D Lawrie
Journal:  Br J Clin Pharmacol       Date:  1976-12       Impact factor: 4.335

4.  Serum procainamide levels as therapeutic guides.

Authors:  J Koch-Weser
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

5.  Procainamide absorption studies to test the feasibility of using a sustained-release preparation.

Authors:  T R Shaw; C R Kumana; C M Kaye; C Padgham; T Kaspi; J Hamer
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

6.  Comparison of the acetylation of procainamide and sulfadimidine in man.

Authors:  K Frislid; M Berg; V Hansteen; P K Lunde
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

7.  Acetylation of procainamide and isoniazid by a rat liver-N-acetyl-transferase.

Authors:  E Kattner; R Dubbels; W Schloot
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

8.  Determination of the acetylator phenotype and pharmacokinetics of some sulphonamides in man.

Authors:  T B Vree; W J O'Reilly; Y A Hekster; J E Damsma; E van der Kleijn
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.